If you take that $16 billion market cap that BIIB fell and divide it by 250 million, which I think will be the fully diluted number of shares outstanding by the time we get TLD, it comes to $64 per shares. I'm pretty sure that's how I got the $63 per share value for a share price for our 16 Sept share price contest. I estimated from the increase in BIIB's share price last July, not the fall that ensued when they dropped the program. The peek to trough market cap change for BIIB is actually $30.17 billion between July 2018 to March 2019. It should be noted that my $63 per share was only the value I assigned for cognitive function increases that I'm hoping we will see when the full data is finally released. Also, of note, the potential market for CKD, if we have success there as well, is larger than the CVD and cognitive market combined. I will be happy to see the TLD come out prior to 16 Sept but at this point I'm not counting on it. It looks like DND may take the cake.

Don’t know about anyone else but I would love to have a $30 billion market cap swing to play with when the trial results come out.

Just a few weeks away now

All IMO, dyodd

tada